Related Experiment Video

Updated: Aug 8, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 19, 2013

IGF-I receptor signaling in a prostatic cancer cell line with a PTEN mutation

K Reiss1, J Y Wang, G Romano

  • 1Kimmel Cancer Center, Thomas Jefferson University, 233 S. 10th Street, 624 BLSB, Philadelphia, Pennsylvania, PA 19107, USA.

Oncogene
|June 13, 2000
PubMed

Insights

Prostate cancer cells with PTEN mutations and low IGF-IR levels may spread by altering cell adhesion and motility. Restoring IRS-1 with IGF-IR re-establishes cancer cell growth and spread potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • LNCaP prostate cancer cells exhibit PTEN mutations, low insulin-like growth factor-1 receptor (IGF-IR) levels, and absent IRS-1.
  • The absence of IRS-1, a PI3-kinase activator, is compensated by PTEN mutations, a PI3-kinase inhibitor.
  • IGF-IR signaling without IRS-1 can induce cell differentiation and growth arrest.

Purpose of the Study:

  • To investigate the relationship between PTEN mutation, IGF-IR, and IRS-1 in prostate cancer metastasis.
  • To determine if these factors collectively promote metastatic spread without compromising growth potential.

Main Methods:

  • Assessing the impact of IRS-1 expression on cell adhesion and motility.
  • Evaluating the effect of IGF-IR overexpression in IRS-1-deficient cells.
  • Examining the combined effect of IGF-IR and IRS-1 on LNCaP cell phenotype.

Main Results:

  • IRS-1 expression enhanced cell adhesion while reducing cell motility.
  • IGF-IR overexpression in IRS-1-absent cells led to growth arrest.
  • Co-expression of IGF-IR and IRS-1 restored the transformed phenotype of LNCaP cells.

Conclusions:

  • Prostate cancer cells may achieve metastatic potential through a mechanism involving PTEN mutations, altered IGF-IR signaling, and IRS-1 absence.
  • This interplay allows for metastatic spread without hindering cancer cell growth.
  • Findings suggest a novel pathway for prostate cancer progression and metastasis.

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...